Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced preoperative fasting time versus ondansetron for postoperative complications in elective orthopedic surgery
IRCT20171216037895N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ondansetron in postoperative nausea and vomiting (PONV) and postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Postoperative pain and Number of postoperative nausea and vomiting episodes. Started Jan 2018; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on IRCT20171216037895N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171216037895N1.